Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Marinus Pharmaceuticals

Marinus is a dynamic pharmaceuticals company dedicated to the discovery, development, and commercialization of drugs to treat serious neurological, psychiatric, and pain disorders.


Contact Details:
21 Business park Drive
Branford
Connecticut
06405
United States of America
Tel:203-315-0566
Fax:203-305-0565
Email:info@marinuspharma.com
WWW:

www.marinuspharma.com/




Loading...

Recent Publications by Marinus Pharmaceuticals:

Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy.
PURPOSE: A pilot study of the safety, tolerability, dose range and...
14th November, 2007
Marinus Pharmaceuticals, Inc., Branford, Connecticut 06405, USA. Epilepsia. 2007 Oct;48(10):1870-4. Epub 2007 Jul 18.
DOI Direct Link

Press Releases on Marinus Pharmaceuticals:

BioPortfolio Logo
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors 29th July, 2009 Marinus Pharmaceuticals, Inc.
BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner
Marinus Pharmaceuticals Raises $20 Million in Series B Financing 10th April, 2009 Marinus Pharmaceuticals, Inc.
Company to Advance Ganaxolone Program for the Treatment of Epilepsy BRANFORD, Conn., April 10 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a developer of drugs to treat serious neurological and
Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures 3rd March, 2009 Marinus Pharmaceuticals, Inc.
BRANFORD, Conn., March 3 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. today announced that it met its primary endpoint for its Phase 2 clinical trial investigating the safety and efficacy of
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer 5th August, 2008 Marinus Pharmaceuticals
BRANFORD, Conn., Aug. 5 /PRNewswire/ -- Marinus Pharmaceuticals, a developer of specialty therapeutics to treat serious neurological, psychiatric and pain disorders, has appointed John Krayacich
Best of Biotechnology on Show in Brisbane 1st November, 2004 Ausbiotech
Best of Biotechnology on Show in Brisbane Biotechnology companies continue to develop leading-edge technologies to benefit human and animal health and the environment. What are these

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 323 times since April 2007, the link to the organisation's website has been followed 48 times

Search for more companies in Branford

Search for more companies in Connecticut



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Marinus Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.